Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127016701 | 12701670 | 1 | I | 20160824 | 20160831 | 20160831 | EXP | IT-ASTRAZENECA-2016SE91899 | ASTRAZENECA | 0.00 | F | Y | 0.00000 | 20160831 | CN | IT | IT |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127016701 | 12701670 | 1 | PS | IRESSA | GEFITINIB | 1 | Oral | U | U | 206995 | TABLET | ||||||||
127016701 | 12701670 | 2 | C | LYRICA | PREGABALIN | 1 | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
127016701 | 12701670 | 1 | Lung neoplasm malignant |
127016701 | 12701670 | 2 | Neuropathy peripheral |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
127016701 | 12701670 | OT |
127016701 | 12701670 | DS |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
127016701 | 12701670 | Appendicitis | |
127016701 | 12701670 | Diarrhoea | |
127016701 | 12701670 | Hypersensitivity | |
127016701 | 12701670 | Intestinal obstruction | |
127016701 | 12701670 | Neuropathy peripheral | |
127016701 | 12701670 | Peritonitis | |
127016701 | 12701670 | Renal failure | |
127016701 | 12701670 | Skin abrasion | |
127016701 | 12701670 | Weight decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |